Bone marrow donors sought to grow cells for future therapies
NCT ID NCT01071577
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collected bone marrow from healthy volunteers and patients to produce bone marrow stromal cells (BMSCs), which are being studied for treating immune and heart diseases. Participants provided a bone marrow sample from the thigh bone. The goal was to create a supply of clinical-grade BMSCs for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bone marrow stromal cells (BMSCs)
- What this could lead to
- If successful, this could provide a source of BMSCs for treating immune and heart conditions like graft-versus-host disease.
- What could go wrong
- This is a tissue collection study, not a treatment trial. It was terminated early, so results may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW STROMAL CELLS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States